Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology
- 1 December 2017
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 67 (6) , 1213-1221
Abstract
No abstract availableKeywords
Funding Information
- Swiss National Science Foundation (P2ZHP3_161691)
This publication has 51 references indexed in Scilit:
- Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancerCancer, 2016
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- 32 INVITED New response evaluation criteria in solid tumors: revised RECIST guideline version 1.1European Journal of Cancer Supplements, 2008
- Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantationJournal of Surgical Oncology, 2006
- Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation†Hepatology, 2005
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolizationLiver Transplantation, 2004
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996